Literature DB >> 20012011

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation.

R K Simmons1, K G M M Alberti, E A M Gale, S Colagiuri, J Tuomilehto, Q Qiao, A Ramachandran, N Tajima, I Brajkovich Mirchov, A Ben-Nakhi, G Reaven, B Hama Sambo, S Mendis, G Roglic.   

Abstract

This article presents the conclusions of a WHO Expert Consultation that evaluated the utility of the 'metabolic syndrome' concept in relation to four key areas: pathophysiology, epidemiology, clinical work and public health. The metabolic syndrome is a concept that focuses attention on complex multifactorial health problems. While it may be considered useful as an educational concept, it has limited practical utility as a diagnostic or management tool. Further efforts to redefine it are inappropriate in the light of current knowledge and understanding, and there is limited utility in epidemiological studies in which different definitions of the metabolic syndrome are compared. Metabolic syndrome is a pre-morbid condition rather than a clinical diagnosis, and should thus exclude individuals with established diabetes or known cardiovascular disease (CVD). Future research should focus on: (1) further elucidation of common metabolic pathways underlying the development of diabetes and CVD, including those clustering within the metabolic syndrome; (2) early-life determinants of metabolic risk; (3) developing and evaluating context-specific strategies for identifying and reducing CVD and diabetes risk, based on available resources; and (4) developing and evaluating population-based prevention strategies.

Entities:  

Mesh:

Year:  2009        PMID: 20012011     DOI: 10.1007/s00125-009-1620-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

3.  Role of the metabolic syndrome in risk assessment for coronary heart disease.

Authors:  Priya Kohli; Philip Greenland
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

4.  Selection of measures in epidemiologic studies of the consequences of obesity.

Authors:  J Stevens; J E McClain; K P Truesdale
Journal:  Int J Obes (Lond)       Date:  2008-08       Impact factor: 5.095

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 6.  The metabolic syndrome: is this diagnosis necessary?

Authors:  Gerald M Reaven
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

7.  Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.

Authors:  Harmon Eyre; Richard Kahn; Rose Marie Robertson; Nathaniel G Clark; Colleen Doyle; Yuling Hong; Ted Gansler; Thomas Glynn; Robert A Smith; Kathryn Taubert; Michael J Thun
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

8.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.

Authors:  Darcy B Carr; Kristina M Utzschneider; Rebecca L Hull; Keiichi Kodama; Barbara M Retzlaff; John D Brunzell; Jane B Shofer; Brian E Fish; Robert H Knopp; Steven E Kahn
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

Review 9.  Distribution of body fat and risk of coronary heart disease in men and women.

Authors:  Dexter Canoy
Journal:  Curr Opin Cardiol       Date:  2008-11       Impact factor: 2.161

10.  Metabolic syndrome and cancer risk.

Authors:  Antonio Russo; Mariangela Autelitano; Luigi Bisanti
Journal:  Eur J Cancer       Date:  2007-12-04       Impact factor: 9.162

View more
  122 in total

1.  Weight loss after laparoscopic adjustable gastric band and resolution of the metabolic syndrome and its components.

Authors:  G J Ooi; L Doyle; T Tie; J M Wentworth; C Laurie; A Earnest; M A Cowley; K Sikaris; C W le Roux; P R Burton; P E O'Brien; W A Brown
Journal:  Int J Obes (Lond)       Date:  2017-03-06       Impact factor: 5.095

Review 2.  Plant-derived therapeutics for the treatment of metabolic syndrome.

Authors:  Brittany L Graf; Ilya Raskin; William T Cefalu; David M Ribnicky
Journal:  Curr Opin Investig Drugs       Date:  2010-10

3.  Race- and sex-specific associations of parental education with insulin resistance in middle-aged participants: the CARDIA study.

Authors:  Teresa Tamayo; David R Jacobs; Klaus Strassburger; Guido Giani; Teresa E Seeman; Karen Matthews; Jeffrey M Roseman; Wolfgang Rathmann
Journal:  Eur J Epidemiol       Date:  2012-05-08       Impact factor: 8.082

4.  The rise and fall of the metabolic syndrome.

Authors:  K Borch-Johnsen; N Wareham
Journal:  Diabetologia       Date:  2010-01-19       Impact factor: 10.122

5.  Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.

Authors:  Amber S Watts; Natalia Loskutova; Jeffrey M Burns; David K Johnson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 6.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

7.  The effectiveness of IDF and ATP-III in identifying metabolic syndrome and the usefulness of these tools for health-promotion in older Taiwanese.

Authors:  M M Chen; A C Tsai
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

8.  Confirmatory factor analysis to assess the measure of adiposity that best fits the diagnosis of metabolic syndrome and relationship to physical activity in adults.

Authors:  Manuel A Gómez-Marcos; María C Patino-Alonso; José I Recio-Rodríguez; Juanjo Antón-Alvarez; Alfredo Cabrejas-Sánchez; Carmen Fernandez-Alonso; Javier Rubio-Galán; Verónica Arce; Luís García-Ortiz
Journal:  Eur J Nutr       Date:  2012-10-16       Impact factor: 5.614

9.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

10.  Relationships of cardiorespiratory fitness with metabolic risk factors, inflammation, and liver transaminases in overweight youths.

Authors:  Dominique Bouglé; Gautier Zunquin; Bruno Sesbouë; Jean-Pierre Sabatier
Journal:  Int J Pediatr       Date:  2010-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.